Trials / Conditions / Lymphocytopenia
Lymphocytopenia
6 registered clinical trials studyying Lymphocytopenia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hema NCT06584006 | The First Affiliated Hospital of Xiamen University | Phase 2 |
| Terminated | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) NCT04927169 | Revimmune | Phase 2 |
| Terminated | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) NCT04426201 | Revimmune | Phase 2 |
| Terminated | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) NCT04442178 | Revimmune | Phase 2 |
| Terminated | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort NCT04407689 | Revimmune | Phase 2 |
| Terminated | InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort NCT04379076 | Revimmune | Phase 2 |